Anti-Cancer Drugs

Home Current Issue Previous Issues Published Ahead-of-Print For Authors Journal Info
Skip Navigation LinksHome > January 2009 - Volume 20 - Issue 1 > The spectrum of 5-fluorouracil cardiotoxicity
Anti-Cancer Drugs:
January 2009 - Volume 20 - Issue 1 - pp 79-80
doi: 10.1097/CAD.0b013e3283165f27
Case Reports

The spectrum of 5-fluorouracil cardiotoxicity

Dalzell, Jonathan R.; Samuel, Leslie M.

Collapse Box

Abstract

Cardiotoxicity is a rare but serious complication of 5-fluorouracil therapy. Coronary vasospasm and, less frequently, acute myocarditis have been identified as underlying mechanisms. We report a case of severe toxicity in a relatively young and fit male patient being treated for metastatic colonic adenocarcinoma displaying characteristics that cannot be explained by either mechanism alone.

© 2009 Lippincott Williams & Wilkins, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Article Tools

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.